Shiho Kitaoka

Prof. Shiho Kitaoka

Hyogo Medical University, Nishinomiya, Japan
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Neuron
Verified
Journal Article
Closed access
XNXiang Nie
Xiang Nie
Shiho KitaokaShiho Kitaoka
Shiho Kitaoka
KTKohei Tanaka
Kohei Tanaka
ESEri Segi-Nishida
Eri Segi-Nishida
YIYuki Imoto
Yuki Imoto
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki

21 March 2012 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
KTKohei Tanaka
Kohei Tanaka
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki
Shiho KitaokaShiho Kitaoka
Shiho Kitaoka
YSYuta Senzai
Yuta Senzai
YIYuki Imoto
Yuki Imoto
SNShuh Narumiya
Shuh Narumiya
Various kinds of stress are thought to precipitate psychiatric disorders, such as major depression. Whereas studies in rodents have suggested a critical role of medial prefrontal cortex (mPFC) in stress susceptibility, the mechanism of how stress susceptibility is determined through mPFC remains unknown. Here we show a critical role of prostaglandin E2(PGE2), a bioactive lipid derived from arachidonic acid, in repeated social defeat stress in mice. Repeated social defeat increased the PGE2level in the subcortical region of the brain, and mice lacking either COX-1, a prostaglandin synthase, or EP1, a PGE receptor, were impaired in induction of social avoidance by repeated social defeat. Given the reported action of EP1 that augments GABAergic inputs to midbrain dopamine neurons, we analyzed dopaminergic response upon social defeat. Analyses of c-Fos expression of VTA dopamine neurons and dopamine turnover in mPFC showed that mesocortical dopaminergic pathway is activated upon social defeat and attenuated with repetition of social defeat in wild-type mice. EP1 deficiency abolished such repeated stress-induced attenuation of mesocortical dopaminergic pathway. Blockade of dopamine D1-like receptor during social defeat restored social avoidance in EP1-deficient mice, suggesting that disinhibited dopaminergic response during social defeat blocks induction of social avoidance. Furthermore, mPFC dopaminergic lesion by local injection of 6-hydroxydopamine, which mimicked the action of EP1 during repeated stress, facilitated induction of social avoidance upon social defeat. Taken together, our data suggest that PGE2-EP1 signaling is critical for susceptibility to repeated social defeat stress in mice through attenuation of mesocortical dopaminergic pathway.

6 February 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
YAYasuhisa Ano
Yasuhisa Ano
TATatsuhiro Ayabe
Tatsuhiro Ayabe
RORena Ohya
Rena Ohya
KKKeiji Kondo
Keiji Kondo
Shiho KitaokaShiho Kitaoka
Shiho Kitaoka
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki
Tryptophan-tyrosine (WY)-related peptides including the β-lactopeptide of the glycine-threonine-tryptophan-tyrosine peptide, β-lactolin, improve spatial memory. However, whether and how the WY dipeptide as the core sequence in WY-related peptides improves memory functions has not been investigated. This study assessed the pharmacological effects of the WY dipeptide on memory impairment to elucidate the mechanisms. Here, we showed that oral administration of dipeptides of WY, tryptophan-methionine (WM), tryptophan-valine, tryptophan-leucine, and tryptophan-phenylalanine improved spontaneous alternation of the Y-maze test in scopolamine-induced amnesic mice. In contrast, tyrosine-tryptophan, methionine-tryptophan, tryptophan, tyrosine, and methionine had no effect. These results indicated that the conformation of dipeptides with N-terminal tryptophan is required for their memory improving effects. WY dipeptide inhibited the monoamine oxidase B activity in vitro and increased dopamine levels in the hippocampus and frontal cortex, whereas tryptophan did not cause these effects. In addition, the treatment with SCH-23390, a dopamine D1-like receptor antagonist, and the knockdown of the hippocampal dopamine D1 receptor partially attenuated the memory improvement induced by the WY dipeptide. Importantly, WY dipeptide improved the spontaneous alternations of the Y-maze test in aged mice. These results suggest that the WY dipeptide restores memory impairments by augmenting dopaminergic activity. The development of supplements rich in these peptides might help to prevent age-related cognitive decline.

1 February 2022 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
Shiho KitaokaShiho Kitaoka
Shiho Kitaoka
Currently used antidepressant drugs target and facilitate the action of monoamine neurotransmission. However, approximately 30% of patients do not respond to these drugs. Therefore, there is an urgent need to develop novel therapeutic targets. Several clinical studies have reported that inflammatory cytokines and neutrophils are increased in the blood of patients with major depression. Since social and environmental stress is a risk factor for mental illnesses such as major depression, many research groups have employed chronic stress models in which mice are repeatedly exposed to stressful events. Chronic stress induces neuroinflammation originating from microglia in the medial prefrontal cortex, leading to depressive-like behavior. Moreover, chronic stress influences peripheral immune cells by activating the sympathetic nervous system and the hypothalamus-pituitary-adrenal gland axis. The infiltration of monocytes expressing interleukin (IL)-1β into the brain is involved in chronic stress-induced elevated anxiety. The penetration of IL-6 derived from monocytes into the nucleus accumbens is involved in chronic stress-induced depression-like behavior. Furthermore, cell-cell and peripheral brain interactions and their molecular basis have been discovered. These findings may pave the way for the development of biological markers and therapeutic drugs.

9 September 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
YAYasuhisa Ano
Yasuhisa Ano
MKMasahiro Kita
Masahiro Kita
Shiho KitaokaShiho Kitaoka
Shiho Kitaoka
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki
The number of patients with mental illnesses is rapidly increasing, and daily lifestyle is closely associated with the development of symptoms. It is suggested that inflammatory molecules derived from microglia play crucial roles for the pathophysiology of depression. In the present study, we discovered that leucine–histidine (LH) dipeptide suppressed activation of primary microglia. The effects of LH dipeptide orally administered were measured using tail suspension test (TST) in mice injected with lipopolysaccharide and social interaction test in mice received social defeat stress. LH dipeptide reduced pro-inflammatory cytokines upon stimulation in microglia. Orally administered LH dipeptide was delivered to the brain and suppressed the production of pro-inflammatory cytokines in the brain and concomitant depression-like behavior in the TST. Moreover, oral administration of LH dipeptide suppressed the induction of depression- and anxiety-like behaviors induced by repeated social defeat stress. These results indicate that LH dipeptide suppressed the activation of microglia and ameliorated depression-associated emotional disturbances. Further, we found that LH dipeptide was abundant in various fermented products. Together with previous epidemiological reports that daily intake of these fermented foods is negatively associated with the incidence of psychiatric diseases, our findings suggest that food rich in LH dipeptide may improve mental health.

15 October 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
TATatsuhiro Ayabe
Tatsuhiro Ayabe
YAYasuhisa Ano
Yasuhisa Ano
RORena Ohya
Rena Ohya
Shiho KitaokaShiho Kitaoka
Shiho Kitaoka
TFTomoyuki Furuyashiki
Tomoyuki Furuyashiki
Scope: Peptides containing tryptophan–tyrosine sequences, including the lacto-tetrapeptide glycine–threonine–tryptophan–tyrosine (GTWY) and β-lactolin, from β-lactoglobulin in whey enzymatic digestion, enhance hippocampus-dependent memory functions, which are blocked by the systemic administration of dopamine D1-like antagonist. In this study, we investigated the role of the hippocampal dopaminergic system in the memory-enhancing effect of β-lactolin. Methods and Results: The results of in vivo microdialysis revealed that oral administration of β-lactolin increased the extracellular concentration of dopamine in the hippocampus and enhanced both spatial working memory, as measured in the Y-maze test, and spatial reference memory, as measured in the novel object location test. These memory-enhancing effects of β-lactolin, but not the baseline memory functions, were impaired by the knockdown of the dopamine D1 receptor subtype in the hippocampus. β-Lactolin also enhanced object memory, as measured by the novel object recognition test. However, D1 knockdown in the hippocampus spared this memory function either with or without the administration of β-lactolin. Conclusions: The present results indicate that oral administration of β-lactolin increases dopamine release and D1 receptor signaling in the hippocampus, thereby enhancing spatial memory, but it may improve object memory via a separate mechanism.